A user planned a protocol of Thymosin Alpha-1 to follow a cycle of BPC-157 and TB-500. Their primary goal for adding TA-1 to their regimen was to manage systemic inflammation.
A user planned a protocol of Thymosin Alpha-1 to follow a cycle of BPC-157 and TB-500. Their primary goal for adding TA-1 to their regimen was to manage systemic inflammation.